BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 11529489)

  • 1. Adenoviral infections and a prospective trial of cidofovir in pediatric hematopoietic stem cell transplantation.
    Hoffman JA; Shah AJ; Ross LA; Kapoor N
    Biol Blood Marrow Transplant; 2001; 7(7):388-94. PubMed ID: 11529489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cidofovir for the treatment of adenoviral infection in pediatric hematopoietic stem cell transplant patients.
    Yusuf U; Hale GA; Carr J; Gu Z; Benaim E; Woodard P; Kasow KA; Horwitz EM; Leung W; Srivastava DK; Handgretinger R; Hayden RT
    Transplantation; 2006 May; 81(10):1398-404. PubMed ID: 16732176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cidofovir for treating adenoviral hemorrhagic cystitis in hematopoietic stem cell transplant recipients.
    Nagafuji K; Aoki K; Henzan H; Kato K; Miyamoto T; Eto T; Nagatoshi Y; Ohba T; Obama K; Gondo H; Harada M
    Bone Marrow Transplant; 2004 Nov; 34(10):909-14. PubMed ID: 15361907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous Cidofovir therapy for disseminated adenovirus in a pediatric liver transplant recipient.
    Carter BA; Karpen SJ; Quiros-Tejeira RE; Chang IF; Clark BS; Demmler GJ; Heslop HE; Scott JD; Seu P; Goss JA
    Transplantation; 2002 Oct; 74(7):1050-2. PubMed ID: 12394854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cidofovir for cytomegalovirus infection and disease in allogeneic stem cell transplant recipients. The Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation.
    Ljungman P; Deliliers GL; Platzbecker U; Matthes-Martin S; Bacigalupo A; Einsele H; Ullmann J; Musso M; Trenschel R; Ribaud P; Bornhäuser M; Cesaro S; Crooks B; Dekker A; Gratecos N; Klingebiel T; Tagliaferri E; Ullmann AJ; Wacker P; Cordonnier C
    Blood; 2001 Jan; 97(2):388-92. PubMed ID: 11154213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Invasive adenoviral infections in T-cell-depleted allogeneic hematopoietic stem cell transplantation: high mortality in the era of cidofovir.
    Symeonidis N; Jakubowski A; Pierre-Louis S; Jaffe D; Pamer E; Sepkowitz K; O'Reilly RJ; Papanicolaou GA
    Transpl Infect Dis; 2007 Jun; 9(2):108-13. PubMed ID: 17461995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of BK virus-associated hemorrhagic cystitis in pediatric hematopoietic stem cell transplant recipients with cidofovir: a single-center experience.
    Kwon HJ; Kang JH; Lee JW; Chung NG; Kim HK; Cho B
    Transpl Infect Dis; 2013 Dec; 15(6):569-74. PubMed ID: 24028353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-risk adenovirus-infected pediatric allogeneic hematopoietic progenitor cell transplant recipients and preemptive cidofovir therapy.
    Anderson EJ; Guzman-Cottrill JA; Kletzel M; Thormann K; Sullivan C; Zheng X; Katz BZ
    Pediatr Transplant; 2008 Mar; 12(2):219-27. PubMed ID: 18307672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of BK virus-associated hemorrhagic cystitis with low-dose intravenous cidofovir in patients undergoing allogeneic hematopoietic cell transplantation.
    Lee SS; Ahn JS; Jung SH; Ahn SY; Kim JY; Jang HC; Kang SJ; Jang MO; Yang DH; Kim YK; Lee JJ; Kim HJ
    Korean J Intern Med; 2015 Mar; 30(2):212-8. PubMed ID: 25750563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenovirus infection in pediatric transplant recipients: are effective antiviral agents coming our way?
    Lopez SMC; Michaels MG; Green M
    Curr Opin Organ Transplant; 2018 Aug; 23(4):395-399. PubMed ID: 29846196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and safety of intravesicular cidofovir in allogeneic HSCT recipients.
    Aitken SL; Zhou J; Ghantoji SS; Kontoyiannis DP; Jones RB; Tam VH; Chemaly RF
    J Antimicrob Chemother; 2016 Mar; 71(3):727-30. PubMed ID: 26612873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cidofovir for adenovirus infections after allogeneic hematopoietic stem cell transplantation: a survey by the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation.
    Ljungman P; Ribaud P; Eyrich M; Matthes-Martin S; Einsele H; Bleakley M; Machaczka M; Bierings M; Bosi A; Gratecos N; Cordonnier C;
    Bone Marrow Transplant; 2003 Mar; 31(6):481-6. PubMed ID: 12665844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenovirus viremia and disease: comparison of T cell-depleted and conventional hematopoietic stem cell transplantation recipients from a single institution.
    Lee YJ; Chung D; Xiao K; Papadopoulos EB; Barker JN; Small TN; Giralt SA; Zheng J; Jakubowski AA; Papanicolaou GA
    Biol Blood Marrow Transplant; 2013 Mar; 19(3):387-92. PubMed ID: 23092814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Poor outcome of adenovirus infections in adult hematopoietic stem cell transplant patients with sustained adenovirus viremia.
    Omar H; Yun Z; Lewensohn-Fuchs I; Pérez-Bercoff L; Orvell C; Engström L; Vuong GK; Ljungman P
    Transpl Infect Dis; 2010 Oct; 12(5):465-9. PubMed ID: 20553439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cidofovir for cytomegalovirus-preemptive therapy in stem cell transplant recipients.
    Kiehl MG; Basara N
    Blood; 2001 Sep; 98(5):1626; author reply 1628. PubMed ID: 11547768
    [No Abstract]   [Full Text] [Related]  

  • 16. Successful treatment with intravesical cidofovir for virus-associated hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation: A case report and a review of the literature.
    Sakurada M; Kondo T; Umeda M; Kawabata H; Yamashita K; Takaori-Kondo A
    J Infect Chemother; 2016 Jul; 22(7):495-500. PubMed ID: 26898668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Occurrence, risk factors and outcome of adenovirus infection in adult recipients of allogeneic hematopoietic stem cell transplantation.
    Hubmann M; Fritsch S; Zoellner AK; Prevalsek D; Engel N; Bücklein V; Mumm F; Schulz C; Stemmler HJ; Jäger G; Ledderose G; Kolb HJ; Hausmann A; Hiddemann W; Moosmann A; Tischer J
    J Clin Virol; 2016 Sep; 82():33-40. PubMed ID: 27428881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful preemptive cidofovir treatment for CMV antigenemia after dose-reduced conditioning and allogeneic blood stem cell transplantation.
    Platzbecker U; Bandt D; Thiede C; Helwig A; Freiberg-Richter J; Schuler U; Plettig R; Geissler G; Rethwilm A; Ehninger G; Bornhäuser M
    Transplantation; 2001 Apr; 71(7):880-5. PubMed ID: 11349720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cidofovir in the Treatment of BK Virus-Associated Hemorrhagic Cystitis after Allogeneic Hematopoietic Stem Cell Transplantation.
    Philippe M; Ranchon F; Gilis L; Schwiertz V; Vantard N; Ader F; Labussiere-Wallet H; Thomas X; Nicolini FE; Wattel E; Ducastelle-Leprêtre S; Barraco F; Lebras L; Salles G; Michallet M; Rioufol C
    Biol Blood Marrow Transplant; 2016 Apr; 22(4):723-730. PubMed ID: 26718666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful cidofovir treatment of adenovirus-associated hemorrhagic cystitis and renal dysfunction after allogenic bone marrow transplant.
    Hatakeyama N; Suzuki N; Kudoh T; Hori T; Mizue N; Tsutsumi H
    Pediatr Infect Dis J; 2003 Oct; 22(10):928-9. PubMed ID: 14579818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.